BioChange Ltd.
Shani Attias Cohen is an accomplished researcher and leader in the field of biomedical engineering, currently serving as the Director of Research Development at BioChange Ltd. since July 2021. Previous roles at BioChange Ltd. include R&D and Preclinical Manager and Research and Development Scientist. Shani pursued a Doctor of Philosophy in Biomedical/Medical Engineering at the Technion - Israel Institute of Technology from August 2016 to July 2021, following a Master’s Degree in Chemical Engineering obtained at Ben-Gurion University of the Negev from 2014 to 2016. Additionally, Shani holds a Bachelor’s Degree in Chemical Engineering from Ben-Gurion University of the Negev, earned between 2010 and 2014.
This person is not in any offices
BioChange Ltd.
BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the healthy Extra Cellular Matrix (ECM) and triggers the body to repair itself. Multiple long-term animal studies confirmed the safety and efficacy of the technology. The company is now selling products in the veterinary market and in tissue engineering research and is committed to start first clinical study in aesthetic dermatology in 2022. Several other products based on the CellFoam platform technology are in development to enrich our pipeline.